Clinical Scorecard: What Metabolic Aging Says About Dementia Risk

At a Glance

Key Highlights

• MileAge delta indicates biologically older metabolic profiles.
• Higher MileAge scores linked to increased risk of vascular dementia and earlier onset of Alzheimer's disease.
• Study analyzed data from 223,496 UK Biobank participants over a median follow-up of 13.7 years.
• Key metabolite groups include lipids, lipoproteins, branched-chain amino acids, and inflammatory markers.
• Elevated MileAge scores combined with APOE ε4 alleles significantly increase dementia risk.

Guideline-Based Recommendations

Diagnosis

• Utilize MileAge scores for early identification of dementia risk.

Management

• Monitor metabolomic profiles in individuals with genetic predispositions.

Monitoring & Follow-up

• Regular assessment of plasma metabolites to track aging and dementia risk.

Risks

• Higher MileAge scores correlate with increased dementia risk, particularly in individuals with APOE ε4 alleles.

Patient & Prescribing Data

Mid-life individuals, especially those with genetic risk factors for dementia.

Focus on managing metabolic health may mitigate dementia risk.

Clinical Best Practices

• Incorporate metabolomic profiling in routine assessments for at-risk populations.
• Consider genetic testing for APOE genotype in conjunction with metabolomic data.

Related Resources & Content

• Alzheimer’s & Dementia Study